Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
trans-4-[Dimethyl(phenyl)silyl]-1-methylpiperidine 1-oxide is a piperidine N-oxide featuring a dimethylphenylsilyl substituent at the 4-position. This compound is classified as an organosilicon compound and a tertiary amine oxide, and it has been noted to play a role as an epitope. As a member of the heterocyclic N-oxide class, it belongs to a group of compounds known for diverse biological activities, including potential anticancer, antibacterial, antihypertensive, antiparasitic, anti-HIV, anti-inflammatory, neuroprotective, and procognitive effects. N-oxides can also function as prodrugs, undergoing reduction in vivo to their corresponding tertiary amines, which may then exert pharmacological actions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on trans-4-[Dimethyl(phenyl)silyl]-1-methylpiperidine 1-oxide.